Sources Sought: Anti-Carfentanil monoclonal antibody (mAb)
Closed Pre-Solicitation Posted
- Solicitation number
- PANMRA-24-P-0000-0044333
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Aberdeen Proving Ground, Maryland, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Army Medical Research Acquisition Activity (USAMRAA), on behalf of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), is seeking market research to identify parties interested in and capable of providing anti-carfentanil monoclonal antibody (mAb) for use in non-human primate research. The key requirements include providing over 4 grams of anti-carfentanil mAb in phosphate buffered saline at a concentration over 75 mg/mL, aliquoted into 5-20 mL vials. The mAb must be generated using Celltheon's Chinese hamster ovary (CHO) cell line, be safe for use in non-human primates, and be delivered to USAMRICD no later than June 1, 2025. The anticipated contract type is firm-fixed price, and responses are due by July 12, 2024.
The requirement may be set aside for small businesses or procured through full and open competition. All small business set-aside categories will be considered. The North American Industry Classification System (NAICS) code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology), and the Product and Service Code (PSC) is 6509-P - Drugs And Biologicals, Veterinary Use. The government has not provided any information about potential incumbents or current contractors, and the budget or anticipated award value has not been specified.
Notice text
The U.S. Army Medical Research Acquisition Activity (USAMRAA) is issuing this sources sought notice (SSN) on behalf of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) as a means of conducting market research to identify parties having an interest in and the resources to support the requirement for Anti-Carfentanil monoclonal antibody (mAb) for use in Non-Human Primates.
Based on the responses to this sources sought notice, this requirement may be set-aside for small business (in full or in part) or procured through full and open competition. All small business set-aside categories will be considered. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions.
***PLEASE SEE THE ATTACHED SOURCES SOUGHT NOTICE***
Files
| File | Type | Posted |
|---|---|---|
| A02. Sources Sought Notice - Celltheon Antibody.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Information – Prophylactic Platform for Medical Countermeasures | ACC Aberdeen Proving Ground | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity